|
JPS5154583A
(en)
*
|
1974-11-01 |
1976-05-13 |
Kyorin Seiyaku Kk |
Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
|
|
US4097483A
(en)
*
|
1974-11-01 |
1978-06-27 |
Kyorin Pharmaceutical Co., Ltd. |
Pyrazolo 1,5-a!pyridines
|
|
US4237300A
(en)
*
|
1975-12-09 |
1980-12-02 |
Merck & Co., Inc. |
Certain 6-substituted-2-pyridinamines
|
|
JPS5968553A
(ja)
*
|
1982-10-13 |
1984-04-18 |
Automob Antipollut & Saf Res Center |
燃料タンク内蔵式燃料ポンプ
|
|
JPS6072975U
(ja)
*
|
1983-10-26 |
1985-05-22 |
ヤンマーディーゼル株式会社 |
燃料ポンプのエア抜き装置
|
|
JPH0621066B2
(ja)
*
|
1984-03-14 |
1994-03-23 |
杏林製薬株式会社 |
３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
|
|
JPS6263520A
(ja)
*
|
1985-09-14 |
1987-03-20 |
Kyorin Pharmaceut Co Ltd |
抗リウマチ剤
|
|
US4925849A
(en)
*
|
1987-06-15 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
Pharmaceutically useful pyrazolopyridines
|
|
JPH01153633A
(ja)
*
|
1987-12-10 |
1989-06-15 |
Kyorin Pharmaceut Co Ltd |
経皮吸収製剤
|
|
EP0355234A1
(en)
*
|
1988-08-25 |
1990-02-28 |
Merrell Dow Pharmaceuticals Inc. |
Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents
|
|
JPH085790B2
(ja)
*
|
1988-11-11 |
1996-01-24 |
杏林製薬株式会社 |
記憶障害改善薬
|
|
JPH0256853U
(enExample)
*
|
1989-10-04 |
1990-04-24 |
|
|
|
JPH06166687A
(ja)
*
|
1990-07-18 |
1994-06-14 |
Senju Pharmaceut Co Ltd |
ピラゾロ〔１，５−ａ〕ピリジン化合物、その製造法および用途
|
|
PL200923B1
(pl)
|
1999-08-21 |
2009-02-27 |
Nycomed Gmbh |
Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
|
|
EA200500234A1
(ru)
|
2002-08-19 |
2005-08-25 |
Пфайзер Продактс Инк. |
Комбинированная терапия гиперпролиферативных болезней
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
JP2006522151A
(ja)
|
2003-04-01 |
2006-09-28 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
不妊症におけるホスホジエステラーゼ阻害剤
|
|
SG141430A1
(en)
|
2003-05-30 |
2008-04-28 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as hmg-co inhibitors
|
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
|
JP2007512337A
(ja)
|
2003-11-21 |
2007-05-17 |
コンビナトアールエックス インコーポレーティッド |
炎症性障害の治療のための方法および試薬
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
BRPI0618379A2
(pt)
|
2005-11-08 |
2011-08-30 |
Ranbaxy Lab Ltd |
processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
|
|
US8067433B2
(en)
|
2005-11-09 |
2011-11-29 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of ophthalmic disorders
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
JP5352452B2
(ja)
*
|
2006-06-06 |
2013-11-27 |
メディシノバ， インコーポレイテッド |
置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法
|
|
ATE547394T1
(de)
|
2006-12-01 |
2012-03-15 |
Bristol Myers Squibb Co |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
|
|
PL2131841T3
(pl)
|
2007-01-30 |
2013-03-29 |
Avigen Inc |
Sposoby leczenia bólu ostrego
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US7536799B2
(en)
*
|
2007-06-07 |
2009-05-26 |
Keson Industries |
Chalk line apparatus with strategically located chalk fill opening
|
|
US20100226881A1
(en)
*
|
2007-07-11 |
2010-09-09 |
Auckland Uniservices Limited |
PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY
|
|
CN101842098A
(zh)
*
|
2007-08-10 |
2010-09-22 |
基因实验室技术有限公司 |
用于治疗病毒感染的含氮的二环化学实体
|
|
JP5263548B2
(ja)
*
|
2007-08-15 |
2013-08-14 |
杏林製薬株式会社 |
イブジラストを有効成分とする脳動脈瘤の予防、形成抑制又は治療剤
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
WO2010005520A2
(en)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
CA2732520A1
(en)
*
|
2008-08-05 |
2010-02-11 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
|
US20100092479A1
(en)
*
|
2008-08-18 |
2010-04-15 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
|
KR101701943B1
(ko)
|
2009-11-13 |
2017-02-02 |
도레이 카부시키가이샤 |
당뇨병의 치료 또는 예방약
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
MX357121B
(es)
|
2011-03-01 |
2018-06-27 |
Synergy Pharmaceuticals Inc Star |
Proceso de preparacion de agonistas c de guanilato ciclasa.
|
|
ES2395801B1
(es)
|
2011-06-23 |
2014-06-06 |
María Carmen PARDINA PALLEJÀ |
"pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
|
|
CN102617579A
(zh)
*
|
2012-03-28 |
2012-08-01 |
黑龙江大学 |
一种异丁司特的制备方法
|
|
EP2958577A2
(en)
|
2013-02-25 |
2015-12-30 |
Synergy Pharmaceuticals Inc. |
Guanylate cyclase receptor agonists for use in colonic cleansing
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
CN105143203A
(zh)
|
2013-04-17 |
2015-12-09 |
辉瑞大药厂 |
用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
|
|
PL3004138T3
(pl)
|
2013-06-05 |
2024-07-29 |
Bausch Health Ireland Limited |
Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
|
|
CA2920856C
(en)
|
2013-08-09 |
2026-03-03 |
Ardelyx, Inc. |
Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
CN108033959A
(zh)
*
|
2018-01-29 |
2018-05-15 |
山东省药学科学院 |
一种异丁司特的化学合成方法
|
|
WO2020150473A2
(en)
|
2019-01-18 |
2020-07-23 |
Dogma Therapeutics, Inc. |
Pcsk9 inhibitors and methods of use thereof
|
|
JP2022533251A
(ja)
|
2019-05-21 |
2022-07-21 |
アルデリックス， インコーポレイテッド |
患者において血清リン酸塩を低下させるための組み合わせ
|
|
CN113387947B
(zh)
*
|
2021-07-12 |
2022-07-01 |
中国科学院成都生物研究所 |
调节雌激素受体合成活性的吡唑并吡啶衍生物
|
|
GB202306663D0
(en)
|
2023-05-05 |
2023-06-21 |
Union Therapeutics As |
Combination therapy
|